Suchergebnisse - "Hirata, Haruhiko"

PubPharm (10)

1

Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs

enthalten in: Scientific reports | 2023

von Tone, M. | Iwahori, K. | Shiroyama, T. | +10

2

Combined small cell lung carcinoma harboring ALK rearrangement : A case report and literature review

enthalten in: Thoracic cancer | 2020

von Niitsu, T. | Shiroyama, T. | Miyake, K. | +14

3

Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells

enthalten in: JCI insight | 2018

von Kinehara, Y. | Nagatomo, I. | Koyama, S. | +32

4

Trastuzumab emtansine suppresses the growth of HER2-positive small-cell lung cancer in preclinical models

enthalten in: Biochemical and biophysical research communications | 2017

von Morimura, O. | Minami, T. | Kijima, T. | +13

5

Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation : Two Case Reports

enthalten in: Medicine | 2017

von Koba, T. | Kijima, T. | Takimoto, T. | +9

6

Favorable response to trastuzumab plus irinotecan combination therapy in two patients with HER2-positive relapsed small-cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2015

von Kinehara, Y. | Minami, T. | Kijima, T. | +14

7

Overcoming chemoresistance of small-cell lung cancer through stepwise HER2-targeted antibody-dependent cell-mediated cytotoxicity and VEGF-targeted antiangiogenesis

enthalten in: Scientific reports | 2013

von Minami, T. | Kijima, T. | Kohmo, S. | +15

8

HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer

enthalten in: Molecular cancer therapeutics | 2012

von Minami, T. | Kijima, T. | Otani, Y. | +10

9

Early [18F]fluorodeoxyglucose positron emission tomography at two days of gefitinib treatment predicts clinical outcome in patients with adenocarcinoma of the lung

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2012

von Takahashi, R. | Hirata, H. | Tachibana, I. | +13

10

Safe and successful treatment with erlotinib after gefitinib-induced hepatotoxicity : difference in metabolism as a possible mechanism

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2011

von Kijima, T. | Shimizu, T. | Nonen, S. | +13

1
[1]